BioSig Technologies, Inc. announced that it has installed a second evaluation system at the Cleveland Clinic. The additional installation will support the medical center's clinical evaluation of the PURE EP™ System and expand physician access to the Company's signal processing technology. Consistent with its stated national commercial strategy, the Company's customer-centered approach aims to maximize the clinical value and deployment of the PURE EP™ System which has gained interest in several electrophysiology labs in the Midwest.

The Company recently expanded its clinical footprint in Illinois with an additional evaluation agreement at a leading medical center in Springfield, the state capital.